These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 19767159)

  • 1. Prescribing policy with dementia drugs: the UK NICE experience.
    Dening T
    Maturitas; 2009 Oct; 64(2):59-60. PubMed ID: 19767159
    [No Abstract]   [Full Text] [Related]  

  • 2. Raw deal for dementia patients in the UK.
    Lancet Neurol; 2007 Oct; 6(10):839. PubMed ID: 17884665
    [No Abstract]   [Full Text] [Related]  

  • 3. NICE recommends drugs for moderate Alzheimer's disease.
    Mayor S
    BMJ; 2006 Jan; 332(7535):195. PubMed ID: 16439382
    [No Abstract]   [Full Text] [Related]  

  • 4. Ten years of cholinesterase inhibitors.
    Rodda J; Walker Z
    Int J Geriatr Psychiatry; 2009 May; 24(5):437-42. PubMed ID: 19367617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients with mild Alzheimer's disease should have access to drugs, says draft NICE guidance.
    Kmietowicz Z
    BMJ; 2010 Oct; 341():c5562. PubMed ID: 20926475
    [No Abstract]   [Full Text] [Related]  

  • 6. Drugs for Alzheimer's disease. Guidelines for prescribing cholinesterase inhibitors in Australia are similar to those in UK.
    Noble JM
    BMJ; 2001 Nov; 323(7321):1128. PubMed ID: 11725756
    [No Abstract]   [Full Text] [Related]  

  • 7. NICE to see the bigger picture.
    Lancet Neurol; 2006 Feb; 5(2):103. PubMed ID: 16426980
    [No Abstract]   [Full Text] [Related]  

  • 8. The treatment of mild Alzheimer's disease post-NICE.
    Connelly PJ; Passmore AP; Lawlor BA
    Int J Geriatr Psychiatry; 2007 Dec; 22(12):1262-3. PubMed ID: 17503543
    [No Abstract]   [Full Text] [Related]  

  • 9. NICE guidelines unfair for Alzheimer's disease.
    Lowery K
    Br J Nurs; 2001 Nov 8-21; 10(20):1314. PubMed ID: 11873223
    [No Abstract]   [Full Text] [Related]  

  • 10. NICE vindicated in UK's High Court.
    Horton R
    Lancet; 2007 Aug; 370(9587):547-8. PubMed ID: 17707735
    [No Abstract]   [Full Text] [Related]  

  • 11. Aligning the evidence with practice: NICE guidelines for drug treatment of Alzheimer's disease.
    Ballard C; Corbett A; Sharp S
    Expert Rev Neurother; 2011 Mar; 11(3):327-9. PubMed ID: 21375436
    [No Abstract]   [Full Text] [Related]  

  • 12. Guideline: dementia drugs' benefits uncertain.
    Voelker R
    JAMA; 2008 Apr; 299(15):1763. PubMed ID: 18413868
    [No Abstract]   [Full Text] [Related]  

  • 13. NICE, devolution and drugs for dementia.
    Findlay DJ
    Br J Hosp Med (Lond); 2007 Feb; 68(2):66-7; discussion 67-9. PubMed ID: 17370701
    [No Abstract]   [Full Text] [Related]  

  • 14. [British court supports limited use of drugs against dementia].
    Gjersvik P
    Tidsskr Nor Laegeforen; 2007 Sep; 127(18):2418. PubMed ID: 17944011
    [No Abstract]   [Full Text] [Related]  

  • 15. Dementia care and cholinesterase inhibitors.
    Page S
    Prof Nurse; 2001 Jul; 16(10):1421-4. PubMed ID: 12026864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Aspects of the report of the IQWiG (Institute for Quality and Cost Effectiveness in Public Health) " Cholinesterase inhibitors in Alzheimer's dementia"].
    Gogol M; Lüttje D; Werner H
    Z Gerontol Geriatr; 2007 Jun; 40(3):192-4. PubMed ID: 17565437
    [No Abstract]   [Full Text] [Related]  

  • 17. The post-modern world of Alzheimer's disease trials: how much is an ADAS-cog point worth in central London?
    Schneider LS
    Int J Geriatr Psychiatry; 2006 Jan; 21(1):9-13. PubMed ID: 16353164
    [No Abstract]   [Full Text] [Related]  

  • 18. Lawyers claim "concession" over drug prescribing for Alzheimer's disease.
    Dyer C
    BMJ; 2007 Jul; 335(7609):11. PubMed ID: 17615199
    [No Abstract]   [Full Text] [Related]  

  • 19. [A reply to Pfizer: Still no reason to change SBU's conclusions on drugs against dementia].
    Edhag O; Norlund A
    Lakartidningen; 2007 Jan 10-16; 104(1-2):55. PubMed ID: 17323745
    [No Abstract]   [Full Text] [Related]  

  • 20. NICE says anti-dementia drugs should be used only for moderate Alzheimer's disease.
    Day M
    BMJ; 2006 Oct; 333(7572):774. PubMed ID: 17038731
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.